Name | Value |
---|---|
Revenues | 56.9M |
Cost of Revenue | 25.4M |
Gross Profit | 31.5M |
Operating Expense | 34.2M |
Operating I/L | -28.9M |
Other Income/Expense | -0.1M |
Interest Income | 0.0M |
Pretax | -29.1M |
Income Tax Expense | 0.7M |
Net Income/Loss | -29.8M |
Meridian Bioscience, Inc. is a life science company specializing in the development, manufacturing, distribution, and sale of diagnostic test kits for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels globally. The company operates through Diagnostics and Life Science segments, offering a range of testing platforms including real-time PCR amplification, isothermal DNA amplification, lateral flow immunoassay, rapid immunoassay, enzyme-linked immunoassays, anodic stripping voltammetry, and urea breath testing. Its products are sold to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories, as well as to in vitro diagnostic manufacturers and researchers in immunological and molecular tests for various applications.